目的探讨穴位注射葛根素注射液对罗哌卡因所致大鼠心脏毒性的影响,初步探讨其作用机制。方法SD雄性大鼠40只,随机分为4组,分别为空白组(A组)、模型组(B组)、葛根素注射液预防组(C组或预防组)、葛根素注射液治疗组(D组或治疗组),每组10只。按2 mg/(kg·min)的速度将0.5%罗哌卡因注射液经大鼠股静脉持续泵入制作模型。空白组大鼠在双侧内关穴注射生理盐水;模型组和治疗组大鼠出现心率失常时在双侧内关穴分别注射生理盐水和葛根素注射液;预防组大鼠在泵入罗哌卡因前30 min在双侧内关穴注入葛根素注射液。记录给药前大鼠的基础心率,给罗哌卡因后到大鼠出现心律失常(以QRS波延长至90 ms)、心搏骤停的时间,计算出相应的罗哌卡因的用量;取心肌组织检测Na+-K+-ATP酶和LDH含量。结果预防组和治疗组大鼠注射罗哌卡因后到出现心律失常、心搏骤停的时间比模型组明显延长,对应的罗哌卡因用量大于模型组,差异均有统计学意义(P<0.05);与模型组比较,预防组和治疗组心肌组织中Na+-K+-ATP酶含量明显升高,LDH含量明显下降,差异均有统计学意义(P<0.05)。结论穴位注射葛根素注射液对罗哌卡因所致的心脏毒性有一定的预防和治疗作用,其机制可能与增强心肌组织Na+-K+-ATP酶活性,抑制LDH活性有关。
ObjectiveTo investigate the effect of acupoint injection Puerarin on ropivacaine infusion induced cardiac toxicity in rats and explore its mechanism. MethodsA total of 40 SD adult male rats were randomly divided into four groups, non-treatment group(group A), model group (group B), Puerarin prevention group (group C), Puerarin treatment group(group D) (n=10).Establish model of rats by intravenous injection 0.5% ropivacaine at a rate of 2mg/(kg·min). Group A was injected with saline in bilateral Neiguan point, group B and group D were injected with saline and Puerarin injection in bilateral Neiguan point when arrhythmia occurs; 30 minutes before pump into ropivacaine, group C was injected with Puerarin injection in bilateral Neiguan point. Heart rate(HR) before administration, and the time of arrhythmia(as QRS extend to 90 ms) and cardiac arrest emergence were recorded, the amount of ropivacaine was calculated, and the content of Na+-K+-ATPase and LDH of myocardium in rats was tested. ResultsThe time of arrhythmia and cardiac arrest emergence in group C and group D were significantly later than those in group B,and the amount of ropivacaine was significantly larger than that in group B (P<0.05); compared with group B, the content of Na+-K+-ATPase of myocardium in group C and group D was significantly increased and the content of LDH was significantly decreased (P<0.05). ConclusionsAcupoint injection Puerarin has the effects of prevention and treatment on the cardiac toxicity induced by ropivacaine infusion, the protection mechanism may be due to increase the content of Na+-K+-ATPase of myocardial and reduce the content of LDH.